6 research outputs found

    Characteristics of food allergy in children: National multicenter study

    Get PDF
    Conference: Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) Location: Lisbon, PORTUGAL Date: JUN 01-05, 2019Background : Food allergies impose a significant burden on the life of the child and the family. In this study, to determine the demographic characteristics of food allergies, we investigated the characteristics of patients with food allergies in different regions of Pediatric Allergy- Immunology departments in Turkey. Method : Turkey ' s National Study of Allergy and Clinical Immunology Society has conducted a Study Group on Food Allergies. 25 centers participated in this multicenter, cross- sectional and descriptive study.European Academy of Allergy and Clinical Immunolog

    MEDICATION-INDUCED PSYCHOTIC REACTION

    No full text

    Diagnosis and management of cow's milk protein allergy in Turkey: Region-specific recommendations by an expert-panel

    No full text
    Cow's milk protein allergy (CMPA) is the most common type of food-allergy in younger Cow's milk protein children. Prognosis is usually good, with most children developing tolerance before school age. allergy; Children may present with a wide spectrum of symptoms that range from mild to severe; skin Consensus report; reactions such as angioedema and urticaria and gastrointestinal symptoms are the most common Turkey presentations of CMPA. Approximately one-third of CMPA patients suffer from multiple food allergies; severe conditions such as anaphylactic shock (9%), eosinophilic esophagitis (4.7%), and food-protein induced enterocolitis (1%) may also develop in some children. Timely and accurate diagnosis and management is essential for proper growth and development of children with CMPA. In this expert consensus report, we aimed to adapt current understandings in the CMPA field to the specific conditions in Turkey and health system to help physicians with their day-to-day decision making.Danone Nutrici

    Treatment of Severe Asthma: Expert Opinion

    No full text
    Ağır astım tüm astımlı hasta popülasyonunun yakla ş ık %10'unu o lu şturur. Astım kontro lünün sorun o ldu ğu b u grup h asta larda acil servis b a şvuru ları, h astane yatışları, iş- güç kayıpları yü kse k oran larda görülür. Dolayısıyla tedavi maliyetleri çok yüksektir ve tümastım maliyetinin %50'si bu grup için h arcanmaktadır. Genellikle yüksek doz in h aler steroid ve uzun etkili beta-2 agonist kombinas- yonu ile kontrol altına alınamayan bu grup h astalarda farklı tedavi seçenekleri denenmektedir. Bu kısa raporda güncel literatür veri- leri derlenerek stan dart tedaviye dirençli a ğır astımlı h astalarda tedavi seçenekleri ülkemiz koşulları da göz önüne alınarak tartışılmış ve gün lük klinik pratik için önerilerde bulunulmuştur.Severe asth matics account 10% of th e all asth matic po pulation. Th ose asth matics wh ose disease is inadequately controlled accoun t for up to half of th e cost for asth ma, because th ey h ave more emer gency room visits, more h ospital admission an d greater absentee- ism from work. New th erapeutic options were tried in th ose patients wh ose asth ma was uncontrolled with stan dart h igh dose in haled corticosteroid and lon g actin gbeta-2 a gonsit combination therapy. In th is paper takin g into account th e con ditions of our country, current literature was reviewed an d treatment options was discussed an d graded recommen dations are made for daily clinical practice in patients with severe treatment-refractory asthma
    corecore